NanoSight reaches profitability with support of UK nanotechnology
24 Jan 2011
Salisbury-based NanoSight, which has developed a unique
nanoparticle characterization system, has recently secured its 250th
sale and has reached profitability for the first time since the company
was established in 2005.
NanoSight’s CEO Jeremy Warren believes support from the NanoKTN, one
of the UK’s primary knowledge-based networks for micro and
nanotechnologies has had significant, commercial impact on the
success of the business.
NanoSight’s technology has been installed worldwide with users
including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor
and Gamble, Roche and Unilever, together with many leading
universities and research institutes.
UK-based NanoSight has developed a revolutionary technique to
view nanoparticles down to the size of several millionths of a
millimetre. This opens previously unimagined possibilities such as
for the development of viral vaccines and drug delivery systems,
both of which require a great deal of precision.
The NanoSight technique measures on a particle-by-particle basis
and so generates high-resolution particle-size distributions,
allowing an accurate and precise measurement of virus or drug
delivery particle numbers and sizes. This has clear implications for
the manufacturing processes as well as helping to optimize the
From their start, NanoSight has attended NanoKTN events as both a
speaker and exhibitor, using them as a means of securing business
contacts within industry and academia. By talking to industry
professionals within the field and by meeting with academics from
leading research institutions and universities, NanoSight has been
able to increase its new business prospects as well as providing the
company with a platform to deliver information about the benefits of
its technology directly to its target audience.
“There is no doubt that the NanoKTN events have been invaluable
to our business, as has the dedicated commitment and support which
has been provided to us by the NanoKTN staff,” explains Warren.
“They have provided us with vital access to the nanotechnology
market, both in the UK and abroad, helping us to develop our market
understanding. Through conferences and focus groups, the NanoKTN has
made the market more coherent, bringing academia and commercial
players together, developing a solid MNT network.”
With continued support from the NanoKTN’s Theme Managers,
NanoSight has been able to develop contact with key market
professionals and generate new sales internationally. NanoSight has
grown rapidly and has secured its position in the market as a
leading manufacturer of unique nanoparticle characterization
technology, more than 90% of sales being outside the UK.
CEO Warren adds, “I would strongly recommend companies joining
the NanoKTN. Membership is essential to those wanting to learn more
about the key players in the nanotechnology market and to help to
build their company profile. Their events have provided us with
valuable networking opportunities and are crucially important to
ensure the growth of the UK nanotechnology market."